Home > Category > ACT-389949

ACT-389949

Glpbio

Catalog No：GC60564-10mg CAS No.：1258417-54-7 MDLNo：C20H18F2N6O3 Brand:Glpbio purity： 特性： Purpose:ACT-389949是一种首创、高效、选择性的甲酰肽受体2/脂蛋白A4受体(FPR2)/(ALX)激动剂，对FPR2/ALX进行内化入单核细胞的EC50值为3nM。ACT-389949具有研究炎性疾病的潜力。DMSO: 10 mg/mL (23.34 mM; ultrasonic and adjust pH to 1 with HCl)

Share

Size	Availability	Price(USD)
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry

Product Overview
Related documents
Related literature

Product Overview

Product Name	ACT-389949
CAS	1258417-54-7
MW	428.39
MDL	C20H18F2N6O3
Storage condition	Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month

Related literature

Sorry, there is no relevant literature

Related

Sorry, no related items

History

ACT-389949

Ribocil-C

STREPTAVIDIN PE

STREPTAVIDIN PE

D-JBD19

SLIDE-A-LYZER, 1.0 ML SYRI

SLIDE-A-LYZER, 1.0 ML SYRI

ANTI-TYROSINASE

ANTI-TYROSINASE

(3aR,3'aR,8aS,8'aS)-2,2'-(2,6-Pyridinediyl)bis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole]

(3aR,3'aR,8aS,8'aS)-2,2'-(2,6-Pyridinediyl)bis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole]

357209-32-6 ≥98%,99%e.e.

cis-ACCP

MD12 NUNCLON SPHERA

MD12 NUNCLON SPHERA

TAK-438